Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA Approves ViMove for Expanded Use in the United States

MELBOURNE, Australia–(BUSINESS WIRE)–Medical device company dorsaVi Ltd (ASX:DVL) has received 510(k) clearance by the US Food and Drug Administration expanding the use of ViMove in the United States. The expanded functionality and labelling is highly significant because for the first time in the USA it permits the use of ViMove to display lower back and […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom